Compliance Question of the Week – Cardiology

For 93503, in 2024, do we need to report modifier -26 for a Swan-Ganz insertion?

What code would we report if the physician does not give LV angiographic data but true diagnostic selective coronary angiography is performed?

We had an interventional cardiologist perform a percutaneous left heart catheterization, then selective injections of the left ventricle and coronary arteries for diagnostic purposes. This was followed by mechanical thrombectomy of the LAD artery with subsequent drug-eluting stent placement in the LAD. How would we code this?

For 2024, how should the utilization of intravascular lithotripsy outside of the coronary arteries be reported, and what specific coding ranges apply for facility and professional fee coding when it comes to its use in the lower extremities?

When do we report codes 37236 and 37237?

Can you please elaborate on the procedure outlined in 0620T so we can better understand when to report this code?

When do you report the new code C1761?

Do you have any tips for 92972?

For 2024, what code do we report for percutaneous transluminal coronary lithotripsy and can you explain more details about the service?

How would we code for the following when it comes to hospital-based services: An interventional cardiologist performs a PTCA in the LAD followed by drug-eluting stent placement in the same vessel, subsequently the physician next performs a PTCA in the RCA.

Can code 93925 be reported for upper extremity scans?

Would we report modifier -26 for a Swan-Ganz insertion on a professional claim?